Insert Cover Image using Slide Master View                                Do not distortCardiovascular Pharmaceuticals Mar...
Executive Summary                   Cardiovascular pharmaceuticals market in India is valued at INR X bn in 20--   Market ...
•Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Market Value Chain, Regulation and Patents•Compe...
Indian cardiovascular pharma market is expected to witness huge growth in the coming years Indian Market – Overview       ...
Drivers & Challenges - Summary  Drivers                                                            Challenges  Increasing ...
Government Initiatives – Summary                             Reduction in drug prices                                     ...
Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information                               ...
Thank you for the attentionThe Cardiovascular Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndus...
Upcoming SlideShare
Loading in...5
×

Market Research Report : Cardiovascular pharmaceuticals market in india 2011

917

Published on

For the complete report, get in touch with us at : info@netscribes.com

Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascular drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, patent expiry of popular blockbuster drugs, increase in disposable income and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various control programmes. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major cardiovascular drug classes. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.
An analysis of the drivers explains the factors for growth of the industry including increasing patient population, patent expiry of blockbuster drugs, increase in disposable income and introduction of newer and better drugs. The key challenges include strong competition between the different pharma companies and competition from complementary and alternative medicines.
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various control programmes undertaken by the Government.
A brief overview of the drug market value chain, drug regulations and patents is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. A snapshot of different regulatory frameworks existing in the Indian pharma industry have been shown. The section also provides a list of important patent approvals for cardiovascular drugs.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
917
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
28
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Market Research Report : Cardiovascular pharmaceuticals market in india 2011

  1. 1. Insert Cover Image using Slide Master View Do not distortCardiovascular Pharmaceuticals Market - IndiaSeptember 2011
  2. 2. Executive Summary Cardiovascular pharmaceuticals market in India is valued at INR X bn in 20-- Market The market is expected to grow at a CAGR of y% from 20----- CVD segment is the second largest contributor to domestic sales, contributing around x % Drivers: Challenges: Increasing patient base Strong competition Drivers and Patent expiry of blockbuster drugs Competition from complementary and Challenges Increasing disposable income Introduction of new drugs Drug value chain PLE alternative medicinesDrug regulation and patents Government Phases of clinical trial SAM Approval and licensing of drugs Patent approvals Reduction in drug prices Changes in tax structure initiatives Control Programmes Highly fragmented market with large number of players Major foreign players in the market include Company 1, Company 2, Company 3 etc Competition Major domestic companies include Company 4, Company 5, Company 6 among others CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 2
  3. 3. •Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Market Value Chain, Regulation and Patents•Competition•Strategic recommendation CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 3
  4. 4. Indian cardiovascular pharma market is expected to witness huge growth in the coming years Indian Market – Overview Market Size and Growth • Cardiovascular therapeutic segment belongs to the INR bn chronic segment (comprising of cardiovascular, anti 150 x6 diabetics and neuro pshychiatry), which together y% x5 account for around A% of the total pharma market 100 x4 x3 x2 • Cardiovascular segment is the second largest x1 50 contributor to domestic pharmaceuticals market sales, with a share of x% 0 2010 2011e 2012e 2013e 2014e 2015e Within the cardiovascular segment, antihypertensive drugs account for almost m% of revenue • Presently the market has a size of INR X bn and is LE Cholesterol lowering drugs account for one third of sales P Top Pharmaceutical Segments – 20-- 0 2 4 6 8 10 12 14 16 18 expected to grow at a CAGR of y% from 20-- to 20-- to reach INR Y bn • Annually, B million Indians die of cardiovascular diseases SAM anti-infectives CVD gastro CNS respiratory diabetes pain Y5 Y6 y7 Y4 Y3 Y2 Y% 1 gynaecology Y8 • According to WHO estimates, by 2020, almost a% of urology y9 oncology Y 10 cardiac patients worldwide will be IndianSource: CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 4
  5. 5. Drivers & Challenges - Summary Drivers Challenges Increasing patient base Strong competition Patent expiry of blockbuster drugs Competition from complementary and alternative medicines Increasing disposable income Introduction of new drugs CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 5
  6. 6. Government Initiatives – Summary Reduction in drug prices Government Initiatives Control programs Changes in tax structure CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 6
  7. 7. Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information Financial Performance Revenue Revenue Profit Headquarters City 1, State 1 INR bn INR bn Profit / Loss Founded 19-- 100 r4 60 r2 r3 r1 40 Products Product 1, Product 2 50 20 E Key People Person X– MD L 0 0 P 2008 2009 2010 2011 Business Highlights SAM • Employing around n people, Company 1 is India’s largest pharmaceutical company, having manufacturing facilities in m countries and serving customers in over n countries • In 20--, the company received the USFDA approval to manufacture and market cardiovascular drug Product Y • In 20--, the company entered into an alliance with Company X, one of the largest Japanese innovator companies to create an innovator and generic pharmaceuticals powerhouse • In 20--, Company 1 entered into an in licensing agreement with Company Y, for the marketing of a fixed dose combination of Product A and Product B, under the brand name Product CSource: CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 7
  8. 8. Thank you for the attentionThe Cardiovascular Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndustry Series.For more detailed information or customized research requirements please contact:Tamojit Roy Gagan UppalPhone: +91 33 4064 6215 Phone: +91 22 4098 7530E-Mail: tamojit.roy@netscribes.com E-Mail: gagan.uppal@netscribes.comResearch on India is a product of Netscribes (India) Pvt. Ltd. Research on India is dedicated to disseminating information and providing quickinsights on “hot” industries in India and other emerging markets. Track our new releases and major updates in these industries onAbout NetscribesNetscribes is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a truevalue proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients’ profitability and growthobjectives.Disclaimer: This report is published for general information only. Although high standards have been used the preparation, Research on India,Netscribes (India) Pvt. Ltd. or “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is thesole property of Netscribes (India) Pvt. Ltd. and prior permission is required for guidelines on reproduction. CARDIOVASCULAR PHARMACEUTICAL MARKET INDIA 2011.PPT 8
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×